As of 2025-07-06, the Fair Value of Parenteral Drugs (India) Ltd (PDPL.NS) is -498.33 INR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.90 INR, the upside of Parenteral Drugs (India) Ltd is -17,283.70%.
With the market price of 2.90 INR and our fair value calculation, Parenteral Drugs (India) Ltd (PDPL.NS) is not a good investment. Investing in PDPL.NS stocks now will result in a potential loss of 17,283.70%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-03-31 | - | - | 5Y Avg | ||
| Net income | -1,250.20 | -763.62 | - | - | -763.62 | |
| YoY growth | -% | 38.92% | - | - | 38.92% | |
| Market Cap (mil) | 86.48 |
| P/E | |
| Forward P/E |
| EPS | -25.61 |
| Avg earnings growth rate | 38.92% |
| TTM earnings | -763.62 |